16th Annual Heart Failure Holiday Symposium

 

16th Annual Heart Failure Holiday Symposium
Avatar

HF Treatment: Can the Use of SGLT2i Provoke Diuresis? How to Clinically Treat Patients at the Bedside?

By 16th Annual Heart Failure Holiday Symposium FEATURING Jane Wilcox, Sanjiv J. Shah, Mark Drazner, Clyde Yancy, Jonathan D. Rich
By 16th Annual Heart Failure Holiday Symposium FEATURING Jane Wilcox, Sanjiv J. Shah, Mark Drazner, Clyde Yancy, Jonathan D. Rich
411 views
February 18, 2021
1 Comment
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus
Videos
25:01
16th Annual Heart Failure Holiday Symposium

New Treatment Approaches to HFrEF: When to Use SGLT2, Vericiguat, Om…

Feat. M. Drazner
17:01
16th Annual Heart Failure Holiday Symposium

Updates in Treatment Approaches to HFpEF: What Is the Phenotype-guid…

Feat. S. Shah
15:35
16th Annual Heart Failure Holiday Symposium

Implications of New HF Therapies on HF Guidelines: Is the SGLT2i Dru…

Feat. C. Yancy
13:55
16th Annual Heart Failure Holiday Symposium

HF Treatment: Can the Use of SGLT2i Provoke Diuresis? How to Clinica…

Feat. J. Wilcox, S. Shah, M. Drazner, C. Yancy, J. Rich
16:50
16th Annual Heart Failure Holiday Symposium

Cardiac Amyloidosis vs. Cardiorenal Syndrome: How to Diagnose and Tr…

Feat. M. Grogan
16:26
16th Annual Heart Failure Holiday Symposium

Updates in Heart Transplantation: How to Use Personalized Medicine i…

Feat. K. Ghafourian
08:33
16th Annual Heart Failure Holiday Symposium

Who Needs a Biopsy for Diagnosing TTR Amyloidosis? What Is the Role …

Feat. J. Rich, M. Grogan, S. Shah, K. Ghafourian